PRMT1 and lung carcinoma: Finally, we found that targeting PRMT1 to reduce persistence is more effective in lung cancer models with intact versus deleted chromosome 5q31.1, a region enriched with JAK-STAT pathway genes, suggesting a potential stratification criterion.